bibliographicCitation |
Wang J, Li X, Wu X, Wang Z, Zhang C, Cao G, Zhang X, Peng F, Yan T. Role of immune checkpoint inhibitor-based therapies for metastatic renal cell carcinoma in the first-line setting: A Bayesian network analysis. EBioMedicine. 2019 Sep;47():78–88. PMID: 31439476; PMCID: PMC6796578. |